Last reviewed · How we verify
Serratia Peritonitis
Approved treatments
- Azactam · Bristol-Myers Squibb
Aztreonam inhibits bacterial cell wall synthesis, acting as a bactericidal agent.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Serratia Peritonitis patent landscape — cliff calendar, originator estates, attackable patents
- Serratia Peritonitis treatment landscape brief
- Serratia Peritonitis treatment updates RSS
Frequently asked questions about Serratia Peritonitis
What drugs treat Serratia Peritonitis?
Tracked treatments include Azactam.
What is the treatment for Serratia Peritonitis?
Standard treatment for Serratia Peritonitis includes Azactam. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Serratia Peritonitis patent cliff · Serratia Peritonitis CI report
- Treatment: Azactam · Bristol-Myers Squibb
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing